go-v.orgdoi

In Vitro Effects Of Dutasteride And Finasteride On Prostate Cancer Cell Growth

— · The Internet Journal of Urology · 2008

  • DOI 10.5580/f2
  • Publisher OpenAlex
  • Type article
  • Issued 2008

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

The Internet Journal of Urology · OpenAlex · article · 2008

Abstract

Introduction: Dutasteride and finasteride are used to treat benign prostatic hyperplasia (BPH). The authors hypothesized that dutasteride and finasteride would affect the growth of prostate cells in vitro. Methods: Three prostate cancer cell lines (LnCaP, PC3, DU145) and one normal line (CRL-2221) were treated in vitro with dutasteride and finasteride. Cell viability was measured at 72 hours by microculture tetrazolium test (MTT) . Results: Dutasteride reduced cell growth (p<0.001), in all cell lines and doses, was tested. Finasteride inhibited cell growth significantly (p<0.05) in the DU145 at 12.5 (57% + 2%), 25 (53% + 4%), and 50 μg/well (59% + 1%).

An increase in cellular proliferation was observed in all cell lines treated with finasteride at doses of 0.4, 0.8, and 1.6 μg/well (range: 134% to 685%, p<0.001). Conclusion: Dutasteride could have application in treatment or prevention of prostate cancer. However, the cellular proliferation by finasteride causes great concern in its widespread use. Presented at the Association of VA Surgeons, May 8, 2006. Cincinnati, OH

Open the resolved locator · 10.5580/f2

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 01:11 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
http://doi.org/10.5580/f2
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.